Targeting ACE2 and TMPRSS2 not only has important prospects as a therapeutic strategy against COVID‐19 and other coronaviruses, especially for cancer patients who may change the expression of these proteins due to malignant tumors or treatments. The gene discussed is TMPRSS2; the disease is cancer.